Cargando…

Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with pulmonary hemorrhage is rare in childhood. Standard treatment includes corticosteroids and cyclophosphamide (CYC), which is associated with a high level of toxicity. We report a white female with ANCA positive pulmonary hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Baird, Emily M, Lehman, Thomas JA, Worgall, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215638/
https://www.ncbi.nlm.nih.gov/pubmed/22032441
http://dx.doi.org/10.1186/1546-0096-9-33
_version_ 1782216408106532864
author Baird, Emily M
Lehman, Thomas JA
Worgall, Stefan
author_facet Baird, Emily M
Lehman, Thomas JA
Worgall, Stefan
author_sort Baird, Emily M
collection PubMed
description Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with pulmonary hemorrhage is rare in childhood. Standard treatment includes corticosteroids and cyclophosphamide (CYC), which is associated with a high level of toxicity. We report a white female with ANCA positive pulmonary hemorrhage who was treated with cyclophosphamide (CYC) and rituximab (RTX) combination therapy.
format Online
Article
Text
id pubmed-3215638
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32156382011-11-15 Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report Baird, Emily M Lehman, Thomas JA Worgall, Stefan Pediatr Rheumatol Online J Case Report Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with pulmonary hemorrhage is rare in childhood. Standard treatment includes corticosteroids and cyclophosphamide (CYC), which is associated with a high level of toxicity. We report a white female with ANCA positive pulmonary hemorrhage who was treated with cyclophosphamide (CYC) and rituximab (RTX) combination therapy. BioMed Central 2011-10-27 /pmc/articles/PMC3215638/ /pubmed/22032441 http://dx.doi.org/10.1186/1546-0096-9-33 Text en Copyright ©2011 Baird et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Baird, Emily M
Lehman, Thomas JA
Worgall, Stefan
Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report
title Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report
title_full Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report
title_fullStr Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report
title_full_unstemmed Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report
title_short Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report
title_sort combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (anca) positive pulmonary hemorrhage: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215638/
https://www.ncbi.nlm.nih.gov/pubmed/22032441
http://dx.doi.org/10.1186/1546-0096-9-33
work_keys_str_mv AT bairdemilym combinationtherapywithrituximabandcyclophosphamideinthetreatmentofantineutrophilcytoplasmicantibodiesancapositivepulmonaryhemorrhagecasereport
AT lehmanthomasja combinationtherapywithrituximabandcyclophosphamideinthetreatmentofantineutrophilcytoplasmicantibodiesancapositivepulmonaryhemorrhagecasereport
AT worgallstefan combinationtherapywithrituximabandcyclophosphamideinthetreatmentofantineutrophilcytoplasmicantibodiesancapositivepulmonaryhemorrhagecasereport